Single-dose Covid vaccine triggers antibody response: Study
New York, Jan 9 : Researchers have developed a nanoparticle vaccine that elicits a virus-neutralising antibody response after a single dose.The team, including Peter Kim from Stanford University in the US, said that the primary target for Covid-19 va…
